HLA—DRB1 genes and disease severity in rheumatoid arthritis
The DOI matches its Crossref record.
Abstract
Objective. To examine the effect of alleles encoding the “shared”/“rheumatoid” epitope on rheumatoid arthritis (RA) disease severity in patients who participated in the minocycline in RA (MIRA) trial. Methods. Of 205 patients with a week‐48 visit, blood was available for typing of HLA‐DRB1 and HLA‐DQB1 in 174 (85%) and successfully completed in 169 (82%). Baseline erosions were used to assess disease severity and new erosions at the last visit served as a proxy for progression. Results. At baseline, there was no association between the presence of erosive disease or rheumatoid factor status and the dose of rheumatoid epitope (homozygous, heterozygous, none) or the specific alleles identified. At the final visit, a gradient was observed for the 3 allelic subgroups (and their gene doses) in the occurrence of new erosions among the Caucasian placebotreated, but not the minocycline‐treated, patients. A treatment group/HLA‐DR4 epitope interaction was demonstrated in multivariate analyses. Approximately two‐thirds of African‐American patients did not have the rheumatoid epitope. Conclusion. HLA‐DRB1 oligotyping may be useful in predicting the progression of disease in some Caucasian patients. Our study corroborates the infrequency of the epitope among African‐American patients with RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Rage and arthritis: The G82S polymorphism amplifies the inflammatory response
Hofmann, M. A., Drury, S., Hudson, B. I., Gleason, M. R., Qu, W., Lu, Y., Lalla, E., Chitnis, S., Monteiro, J., Stickland, M. H., et al. (2002) · Genes & Immunity · doi:10.1038/sj.gene.6363861 · Cited by 383
Alarcón, G. S., Friedman, A. W., Straaton, K. V., Moulds, J. M., Lisse, J., Bastian, H. M., McGwin, G., Bartolucci, A. A., Roseman, J. M., & Reveille, J. D. (1999) · Lupus · doi:10.1191/096120399678847704 · Cited by 309
Self-citationState-of-the-art: rheumatoid arthritis
McInnes, I. B., & O'Dell, J. R. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.134684 · Cited by 303
Honorati, M. C., Meliconi, R., Pulsatelli, L., Canè, S., Frizziero, L., & Facchini, A. (2001) · Rheumatology · doi:10.1093/rheumatology/40.5.522 · Cited by 99
Metadata
- Authors
- Reveille, J. D., Alarcón, G. S., Fowler, S. E., Pillemer, S. R., Neuner, R., Clegg, D. O., Mikhail, I. S., Trentham, D. E., Leisen, J. C. C., Bluhm, G., Cooper, S. M., Duncan, H., Tuttleman, M., Heyse, S. P., Sharp, J. T., Tilley, B., & For the MIRA trial group
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1996-11
- Volume
- 39
- Issue
- 11
- Pages
- 1802-1807
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2042282135
- Cited by
- 49
- References
- 0
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HLA—DRB1 genes and disease severity in rheumatoid arthritis. https://app.cochat.ai/papers/10.1002/art.1780391105
- The paper
- Reveille, J. D., Alarcón, G. S., Fowler, S. E., Pillemer, S. R., Neuner, R., Clegg, D. O., Mikhail, I. S., Trentham, D. E., Leisen, J. C. C., Bluhm, G., Cooper, S. M., Duncan, H., Tuttleman, M., Heyse, S. P., Sharp, J. T., Tilley, B., & For the MIRA trial group. (1996). HLA—DRB1 genes and disease severity in rheumatoid arthritis. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780391105
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.